doi: 10.3389/fphar.2023.1228722 Received 25 May 2023 Accepted 26 June 2023 Published 04 July 2023 Volume 14 - 2023 Edited by Aliyu Muhammad, Ahmadu Bello University, Nigeria Reviewed by Abdurrahman Pharmacy Yusuf, Federal University of Technology Minna, Nigeria Kang-Hoon Kim, Monell Chemical Senses Center, United States Updates Copyright 2023 Wu, Xia, Guo, Wang, Dong, Lu and Yuan
When combined with your clinical history, metabolic markers, and state Medicaid policies, genetic insights can support a more informed conversation with your provider about which GLP-1 formulation (compounded semaglutide, tirzepatide, or other options) may align best with your individual biology
Lamikanra AA, Brown D, Potocnik A, Casals-Pascual C, Langhorne J, Roberts DJ
Calabrese et al., 2021
127 No reported adverse effects were observed in this trial
Harnessing the power of nutritional antioxidants against adrenal hormone imbalance-associated oxidative stress. Frontiers in Endocrinology vol